消息人士：Anthropic表示，基石投资者将在IPO中出售23,333,331股股票。

Shanghai municipal Food and Drug Safety Committee issued its 15th Five-Year plan to ensure drug safety and promote high-quality pharmaceutical development, calling for targeted supervision of priority fields and products. It mandates establishment of accountability and risk‑sharing mechanisms for contract manufacturing and enforcement of quality‑and‑safety responsibilities defined in contract manufacturing agreements. The plan orders intensified on-site inspections at vaccine producers and full-coverage targeted supervision for vaccines, blood products, advanced therapy drugs, sterile pharmaceuticals, special-category medicines and products with segmented production processes, with emphasis on data reliability, sterility assurance, deviation control and change management. It also tightens oversight of implantable and sterile medical devices and devices selected via centralized procurement, requires one-product/one-policy regulatory plans for innovative devices, and steps up checks on procurement of critical raw materials, finished‑product testing and release. Separately, Shanghai will launch a production quality-management upgrade for cosmetics manufacturers, prioritizing special-use cosmetics and products using new raw materials and strengthening raw‑material controls.

Eurogroup chair Pierrakakis said it would be ideal to decide on the next European Central Bank president before year-end.